Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial

OBJECTIVE: The Action to Control Cardiovascular Risk in Diabetes lipid study (ACCORD Lipid), which compared the effects of simvastatin plus fenofibrate (FENO-S) versus simvastatin plus placebo (PL-S) on cardiovascular disease outcomes, measured only fasting triglyceride (TG) levels. We examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes-Soffer, Gissette, Ngai, Colleen I., Lovato, Laura, Karmally, Wahida, Ramakrishnan, Rajasekhar, Holleran, Stephen, Ginsberg, Henry N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554305/
https://www.ncbi.nlm.nih.gov/pubmed/23033246
http://dx.doi.org/10.2337/dc11-2556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554305/
https://www.ncbi.nlm.nih.gov/pubmed/23033246
http://dx.doi.org/10.2337/dc11-2556

Ejemplares similares